All SARS-CoV-2 articles – Page 10
-
NewsStudy uncovers how Covid-19 is so good at defeating the innate immune response
The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell’s innate defense mechanism against viruses, explaining why it is more infectious than the previous SARS and MERS-causing viruses.
-
NewsCOVID study reveals virus-induced inflammation during pregnancy, redefines vertical transmission
A protein made by SARS-CoV-2 can pass through the placenta and cause serious inflammatory immune responses in the fetus for 66% of pregnancies.
-
NewsScientists discover series of SARS-CoV-2 mpro inhibitors for potential COVID-19 treatments
New research has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and synergizes with existing anti-COVID therapies.
-
NewsStudy finds persistent infection could explain long COVID in some people
Researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.
-
NewsPeptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells
The synthetic peptide was inspired by ACE2, the protein to which the virus that causes COVID-19 binds to invade human cells. The results point to a route for the development of novel antivirals.
-
NewsNew mouse models offer valuable window into COVID-19 infection
Scientists have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19 because their cells were engineered to include two important human molecules that are involved in infection of human cells.
-
NewsHigh-throughput modular click chemistry synthesis of catechol derivatives to target Covid protease
Researchers performed high-throughput synthesis of catechol derivatives from the bioactive catechol-terminal alkyne scaffold A4, by using modular click chemistry, in a bid to target the Covid virus’s 3C-like protease (3CLpro).
-
News$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
-
NewsStudy IDs novel small-molecule inhibitors of SARS-CoV-2 with chemical genetics
A new article discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.
-
NewsCovid’s ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites
A new study discusses how SARS-CoV-2 ORF10 hijacking ubiquitination machinery reveals potential unique drug targeting sites.
-
NewsStudy charts spectrum of febrile rash illness in China from 2009 to 2021
A new study monitors the spectrum of viral pathogens involved in febrile rash illness (FRI) and their epidemiology.
-
NewsAnalysis sheds light on COVID-19-associated fungal disease in Japan
Researchers in Japan pored through data to understand the incidence in Japan of COVID-19-associated pulmonary aspergillosis (CAPA), a severe invasive fungal infection of the lungs.
-
NewsNew testing system using Janus particles rapidly and accurately detects COVID-19
Researchers have developed a new quantitative testing system called the ’Express Biochecker’, which provides a simple, rapid, and low-cost method for detecting the coronavirus N protein.
-
NewsOrigami paper sensors could help early detection of infectious diseases in low-cost test
Researchers have developed an innovative new method for identifying biomarkers in wastewater using origami-paper sensors, enabling the tracking of infectious diseases using the camera in a mobile phone.
-
NewsGenetic tracing at the Huanan Seafood market supports COVID animal origins
A study provides a list of the wildlife species present at the market from which SARS-CoV-2 most likely arose in late 2019, based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC).
-
NewsLow-power laser can selectively detect coronavirus spike proteins in just five minutes
Researchers have demonstrated a method to detect the presence of viruses quickly, using only a small sample. The light-induced immunoassay coated with novel coronavirus spike proteins was highly sensitive even with weak light like a laser pointer.
-
NewsAntiviral-resistant variants of SARS-CoV-2 can emerge in immunocompromised people
Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population.
-
NewsStudy sheds light on how virus-fighting cells develop during long Covid
A new long-term study into long COVID has investigated how a certain population of white blood cells, called memory T cells, are established and develop as part of the body’s defense to fight off the disease.
-
NewsUS COVID-19 rates show oscillating waves every six months
COVID-19 cases in the U.S. have shown unexpected oscillating waves every six months between the southern states and the northern states and, to a lesser degree, from east to west, according to new research.
-
NewsScientists discover dual roles of antibodies in COVID-19 infections
A new study has discovered an antibody that can both assist and block a virus. This particular antibody helps pre-Omicron variants of the virus infect cells while preventing the Omicron variant from doing the same.